Pharmaceutical Industry Blog

Last Updated: July 18, 2026 TL;DR: Morocco — a nation of more than 38 million people with one of Africa's most developed health systems and its second-largest pharmaceutical industry, running from the CHU university hospitals in Rabat, Casablanca, Fez, Oujda, Marrakech and Tangier down to regional and provincial hospitals and a growing primary-care network under a universal health-insurance scheme (AMO) that now covers most of the population — depends on a reliable, compliant

Last Updated: July 18, 2026 TL;DR: Angola — a nation of more than 39 million people whose public-sector-led health system reaches from national and central hospitals in Luanda down to provincial hospitals in Huambo, Benguela, Lubango, Cabinda and Malanje and a wide network of municipal hospitals and health centres, and which imports the large majority of its finished medicines and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of

Last Updated: July 17, 2026 TL;DR: Yemen — a nation of more than 41 million people whose health system is being sustained and rebuilt under great strain, running from referral and teaching hospitals in Sana'a, Aden, Taiz, Hodeidah and Mukalla down to governorate hospitals, district hospitals and primary health-care units, and which imports the large majority of its finished medicines and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant su

Last Updated: July 17, 2026 TL;DR: Afghanistan — a nation of more than 43 million people whose health system is being rebuilt and sustained across a large, mountainous, landlocked territory, running from national and regional hospitals in Kabul, Herat, Mazar-i-Sharif, Kandahar and Jalalabad down to provincial hospitals and thousands of basic and comprehensive health centres, and which imports more than 95% of its medicines and almost all of its active pharmaceutical ingredien

Last Updated: July 16, 2026 TL;DR: Argentina — a nation of more than 45 million people with one of Latin America's strongest and most self-sufficient pharmaceutical industries, a founding member of Mercosur and home to ANMAT, a PAHO/WHO reference regulatory authority — depends on a reliable, compliant supply of the specialty and critical-care injectables it needs, together with active pharmaceutical ingredients and technology-transfer partners. Every imported sterile injectab

Last Updated: July 16, 2026 TL;DR: Iraq — a nation of more than 47 million people whose health system is rebuilding across federal governorates and the Kurdistan Region, running from teaching hospitals in Baghdad, Basra, Mosul and Erbil down to general and district hospitals and primary health centres, and which imports the large majority of its finished pharmaceuticals and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of steril